Formulation and Drug Delivery

GSK Ships Seasonal Influenza Vaccines for US Market

July 17, 2017

GSK plans to deliver up to 40 million doses of its quadrivalent flu vaccine for the 2017–2018 season.

Eli Lilly Resolves Patent Litigation Over Cialis

July 12, 2017

The company has entered into a settlement agreement with generic-drug companies to resolve patent litigation.

Pfizer Picks Catalent to Manufacture Newly Launched Pain-Relief Product

July 12, 2017

Pfizer’s new format of ibuprofen (AdvilR Liqui-GelsR Minis) uses Catalent’s softgel technology to deliver the formulation in a more concentrated fill, resulting in smaller capsules.

Antibiotic Nanoparticles Target Drug-Resistant Bacteria

July 12, 2017

New study shows that an antimicrobial peptide packaged in a silicon nanoparticle significantly reduced bacteria load in the lungs of mice infected with Pseudomonas aeruginosa.

Sanofi Acquires Protein Sciences

July 11, 2017

The acquisition will add recombinant-based influenza vaccine to Sanofi Pasteur’s portfolio

ABEC Releases 4000-L Single-Use Bioreactor

July 11, 2017

ABEC increases the maximum capacity of its Custom Single Run Bioreactors to 4000 L, doubling the industry standard.

CordenPharma, GE Healthcare Partner to Speed Development

July 11, 2017

GE Healthcare’s Dharmacon business and CordenPharma contract manufacturing enter a strategic collaboration to accelerate the oligonucleotide development process.

Endo Withdraws Opioid Drug from Market

July 10, 2017

After FDA found a “significant shift in the route of abuse,” Endo voluntarily removes OPANA ER from the market.

Topical Drug Developer Plans IPO

July 06, 2017

Sienna Biopharmaceuticals has filed for an IPO, expecting to raise over $74 million

Biosimilars Overcome Legal and Analytical Hurdles

July 05, 2017

A Supreme Court decision and improvements in analytical processes may speed the biosimilar approval process.